Venous Thrombotic and Thromboembolic Considerations in Stroke: An Expert Meeting Report on Future Directions for Clinical Trials
International Journal of Stroke · 19.07.2026
DOI: 10.1177/17474930261473348 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Stroke, online erschienen am 19.07.2026. Verfasst von Diana N Vikulova und 32 weiteren Autor:innen. Beteiligte Einrichtung: Vancouver Stroke Program, Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Die Arbeit nennt 48 Literaturangaben. Gefördert von: canadian institutes of health research.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Venous thrombosis and venous thromboembolism (VTE) are important causes and complications of stroke. They may complicate acute stroke as deep venous thrombosis or pulmonary embolism (DVT/PE), contribute causally to ischemic stroke through paradoxical embolism from a patent foramen ovale (PFO), or present directly as cerebral venous thrombosis (CVT). Despite shared pathophysiological features and overlapping antithrombotic strategies, these conditions are typically considered separately, fragmenting evidence and limiting the exchange of concepts.
Purpose
We therefore convened experts across both stroke neurology and thrombosis medicine fields to examine these conditions under a unifying venous theme and define priorities for future clinical trials.
Methods
Thirty-two stroke and thrombosis clinicians and researchers identified research priorities across three domains: prevention of VTE after stroke, secondary prevention after PFO-related stroke, and acute and long-term management of CVT. Structured discussions were guided by the PICO (Population, Intervention, Comparison, Outcome) framework, followed by a Delphi survey to establish consensus. Priority questions centered on the balance between thrombosis prevention and bleeding risk and the optimal timing, duration, and choice of DVT/PE prophylaxis after stroke; the optimal antithrombotic strategy for patients awaiting or forgoing PFO closure; and, for CVT, the role of endovascular therapy in severe disease and the optimal duration of secondary prevention (Graphical Abstract). Across domains, the group prioritized pragmatic and platform trial designs, integration with international registries to address the rarity of CVT, and patient-oriented outcomes that extend beyond functional recovery.
Conclusions
By considering these venous conditions together and bridging stroke and thrombosis disciplines, this work defines priority questions to address persistent evidence gaps, harmonize practice, and improve patient-centered outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vancouver Stroke Program, Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
- Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
- Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
- Division of Neurology, Department of Medicine, McMaster University and Population Health Research Institute, Hamilton, ON, Canada.
- Department of Clinical Neurological Sciences, Schulich School of Medicine & Dentistry, and Heart & Brain Lab, Western University, London, ON, Canada.
- Department of Epidemiology & Biostatistics, Schulich School of Medicine & Dentistry, and Heart & Brain Lab, Western University, London, ON, Canada.
ORCID-Profile: Diana N Vikulova, Lily Zhou, Ronda Lun, Katrina Hd Ignacio, Aravind Ganesh, Aristedis H Katsanos, Sara Db Rosa, Diana Aguiar de Sousa, Cheryl Carcel, Nishita Singh, Bethany T Samuelson Bannow, Chen Chen, Mirjam R Heldner, Menglu Ouyang, Emily R Ramage, Ronen R Leker, Thalia S Field
Förderung
- canadian institutes of health research
Zitieren
APA
Vikulova, D. N., Dizonno, V., Zhou, L., Gorman, J., Lun, R., Ignacio, K. H., Bushnell, C. D., Ganesh, A., Katsanos, A. H., Sposato, L. A., Rosa, S. D., Fuerte-Hortigon, A., Aguiar de Sousa, D., Carcel, C., Singh, N., Wan, T., Samuelson Bannow, B. T., Bian, H., Chen, C., …, & Field, T. S. (2026). Venous Thrombotic and Thromboembolic Considerations in Stroke: An Expert Meeting Report on Future Directions for Clinical Trials. International Journal of Stroke. https://doi.org/10.1177/17474930261473348
Vancouver
Vikulova DN, Dizonno V, Zhou L, Gorman J, Lun R, Ignacio KH, et al. Venous Thrombotic and Thromboembolic Considerations in Stroke: An Expert Meeting Report on Future Directions for Clinical Trials. International Journal of Stroke. 2026. doi:10.1177/17474930261473348
BibTeX
@article{Vikulova2026,
author = {Vikulova, Diana N and Dizonno, Vanessa and Zhou, Lily and Gorman, Johnathon and Lun, Ronda and Ignacio, Katrina Hd and Bushnell, Cheryl D and Ganesh, Aravind and Katsanos, Aristedis H and Sposato, Luciano A and Rosa, Sara Db and Fuerte-Hortigon, Alejandro and Aguiar de Sousa, Diana and Carcel, Cheryl and Singh, Nishita and Wan, Tony and Samuelson Bannow, Bethany T and Bian, Hetao and Chen, Chen and Coutinho, Jonathan M and Demchuk, Andrew M and Doshi, Darshan and Farhoudi, Mehdi and Fonseca, Ana Catarina and Fu, Vivian and Heldner, Mirjam R and Ouyang, Menglu and Ramage, Emily R and Sebastian, Ivy and Leker, Ronen R and Anderson, Craig S and Menon, Bijoy K and Field, Thalia S},
title = {Venous Thrombotic and Thromboembolic Considerations in Stroke: An Expert Meeting Report on Future Directions for Clinical Trials},
journal = {International Journal of Stroke},
year = {2026},
doi = {10.1177/17474930261473348}
}
EUVIMED